SEC Form D · filed June 16, 2021
Tvardi Therapeutics, Inc
Offering
$75.1M
Sold
$72.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOUSTON, TX
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (10)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗